COVID-19 Vaccines: What Vaccinated People Should Know About Breakthrough Infections, Protection, and Safety

Vaccination lowers the risk of severe COVID-19, but infections can still occur. Understanding how vaccines work, their benefits, and their limitations can help people make informed health decisions.

COVID-19 remains a respiratory illness that can affect people differently. Some experience mild symptoms, while others develop complications that require hospitalization. Although vaccination has significantly changed the way healthcare professionals prevent severe disease, it does not provide an absolute guarantee against infection.

The headline suggesting that people vaccinated against COVID-19 may become sick needs important context. Vaccinated people can still catch COVID-19, but this does not mean the vaccines have failed. Protection against infection can vary over time and with the emergence of new variants, while protection against severe illness may remain meaningful.

Understanding the difference between preventing every infection and reducing the risk of serious outcomes is essential when evaluating information about COVID-19 vaccines.

How COVID-19 Vaccines Work

COVID-19 vaccines help the immune system recognize SARS-CoV-2, the virus responsible for the disease. Depending on the vaccine platform, vaccination exposes the immune system to instructions or components that allow it to recognize a particular viral protein.

The immune system can then develop antibodies and cellular responses that help it respond if the person encounters the virus later. These defenses do not always prevent the virus from entering the body or beginning to reproduce, but they can help the body respond more effectively.

Several vaccine technologies have been used against COVID-19. Messenger RNA vaccines, such as those developed by Pfizer-BioNTech and Moderna, provide temporary instructions that allow cells to produce a harmless viral protein for immune recognition. Protein-based vaccines use a component of the virus to stimulate an immune response. Adenovirus-vector vaccines have also been used in some countries.

Although the technologies differ, their shared purpose is to prepare the immune system to recognize the virus.

Immune protection is not identical for everyone. Age, underlying health conditions, previous infections, the time since vaccination, and the particular variant circulating in a community can all influence the level of protection a person has.

That is why public-health recommendations may change as evidence develops and vaccine formulations are updated.